When do carcinogen-treated 10T1/2 cells acquire the commitment to form transformed foci?
D015123:7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; D000818:Animals; D001580:Benzopyrenes / Q000494:pharmacology; D002273:Carcinogens; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D002478:Cells, Cultured; D004351:Drug Resistance; D051379:Mice; D010042:Ouabain / Q000494:pharmacology; D013997:Time Factors
D001580:Benzopyrenes; D002273:Carcinogens; D015123:7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; D010042:Ouabain